Monroe Capital (MRCC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Mar, 2026Executive summary
Supplement amends and updates the joint proxy statement/prospectus for a proposed transaction between two entities, referencing recent annual and current reports for both parties.
Voting matters and shareholder proposals
Shareholders are being asked to review and vote on matters related to the joint proxy statement/prospectus, as updated by this supplement.
Board of directors and corporate governance
The supplement is issued jointly by both entities, indicating coordinated governance and oversight for the proposed transaction.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Monroe Capital
- Meeting adjourned for lack of quorum; all business postponed to August 11th, 2026.MRCC
AGM 2026 - Director elections and share sale flexibility approved; no shareholder questions raised.MRCCAGM 2025
- Meeting adjourned for lack of quorum and rescheduled for July 28, 2026.MRCCAGM 2026
- Both asset sale and merger proposals were approved by a majority of outstanding shares.MRCCEGM 2026
- Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCCProxy Filing
- Net investment income and NAV declined year-over-year, with merger expected to unlock value.MRCCQ4 2025
- Shareholders to vote on merger and asset sale, with NAV-based share exchange and fee waiver.MRCCProxy Filing
- Adjusted NII rose to $0.31/share, covering the dividend as NAV and leverage declined.MRCCQ2 2024
- Director election and share sale authorization approved; no shareholder questions raised.MRCCAGM 2024